Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication

摘要

A transdermal or transmucosal pharmaceutical form for the treatment of nicotine dependency or disaccustoming smokers which comprises nicotine, a nicotine salt, a nicotine derivative or a nicotinergic substance in combination with at least one further active substance comprises at least one substance which acts on the central nervous system and is selected from the group of psychopharmaceuticals which embraces the active-substance groups of the antidepressants, transquilizers, nootropics, neuoleptics, or psychomimetics.